Safety and Efficacy Study of Subjects With Onychomycosis of the Great Toenail

NCT00679523 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Onychomycosis

Interventions

DRUG: AN2690 Solution, 5.0%
DRUG: AN2690 Solution, 7.5%

Sponsor

Pfizer